Table of Contents Table of Contents
Previous Page  1536-1537 / 2063 Next Page
Information
Show Menu
Previous Page 1536-1537 / 2063 Next Page
Page Background

EGFR inhibition + RCT in HNSCC

Other EGFR inhibitors

? CONCERT trials

CONCERT-1: addition of

panitumumab to standard

fractionation radiotherapy and

cisplatin did not confer any benefit

CONCERT-2: panitumumab

cannot replace cisplatin in

combined treatment with RT